510(k) K201690

Mirage Hydrophilic Guidewire; X-pedion Hydrophilic Guidewire by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular — Product Code DQX

K201690 is an FDA 510(k) premarket notification submitted by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular for the device "Mirage Hydrophilic Guidewire; X-pedion Hydrophilic Guidewire". The FDA issued a decision of Substantially Equivalent on July 21, 2020. The device falls under product code DQX (Wire, Guide, Catheter), a Class II device regulated under 21 CFR 870.1330. Micro Therapeutics, Inc. d/b/a ev3 Neurovascular has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
July 21, 2020
Date Received
June 22, 2020
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Wire, Guide, Catheter
Device Class
Class II
Regulation Number
870.1330
Review Panel
CV
Submission Type